02/07/2026
๐ง๐ต๐ฒ ๐ฝ๐ฟ๐ผ๐ฏ๐น๐ฒ๐บ ๐ป๐ผ ๐ผ๐ป๐ฒ ๐ฝ๐ฟ๐ฒ๐ฝ๐ฎ๐ฟ๐ฒ๐ ๐ฝ๐ฎ๐๐ถ๐ฒ๐ป๐๐ ๐ณ๐ผ๐ฟ ๐๐ถ๐๐ต ๐๐๐ฃ-๐ญ๐
๐Many people start a GLP-1 medication and feel like something finally clicks.
Hunger quiets. Food noise fades. Weight drops. Blood sugar stabilizes. ๐ฝ๏ธ
The same behaviors that once felt impossible suddenly feel manageable.
๐Then โก๏ธ months laterโก๏ธ something shifts.
๐ญ Appetite creeps back. Weight loss slows or stalls. The same dose feels ineffective!
๐๐ป Patients assume they did something wrong. Clinicians often escalate the dose.
๐ But this isnโt a failure of willpower or compliance.
Itโs a predictable biological response. ๐งฌ
๐๐ปGLP-1 receptor agonists work by temporarily shifting appetite signaling, gastric emptying, and energy balance. While theyโre on board, they blunt the bodyโs natural defense against weight loss.
๐๐๐ ๐ต๐๐บ๐ฎ๐ป ๐บ๐ฒ๐๐ฎ๐ฏ๐ผ๐น๐ถ๐๐บ ๐ฑ๐ผ๐ฒ๐๐ปโ๐ ๐ฝ๐ฎ๐๐๐ถ๐๐ฒ๐น๐ ๐ฎ๐ฐ๐ฐ๐ฒ๐ฝ๐ ๐๐ฒ๐ถ๐ด๐ต๐ ๐น๐ผ๐๐. ๐๐ ๐๐ฒ๐ถ๐ด๐ต๐ ๐ฑ๐ฟ๐ผ๐ฝ๐:
โข Hunger signals rise
โข Satiety signals fall
โข The brain becomes more sensitive to food cues
โข Energy expenditure subtly declines
๐๐ปOver time, the nervous system adapts. The signal-to-noise ratio changes.
The medication may still be improving glucose, lipids, and cardiometabolic risk ๐๐ป even as weight loss slows.
๐ฃ๐น๐ฎ๐๐ฒ๐ฎ๐ ๐ถ๐ ๐ป๐ผ๐ ๐ณ๐ฎ๐ถ๐น๐๐ฟ๐ฒ.
Adaptation is not the drug โstopping.โ
๐Longevity-focused care requires acknowledging this biology not ignoring it.
๐ฌ Comment โGLP1โ to get my latest Substack where I break down the research and what this means for long-term metabolic strategy.